Joseph W. Ramelli - Net Worth and Insider Trading

Joseph W. Ramelli Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joseph W. Ramelli owns 1 companies in total, including Adhera Therapeutics Inc (ATRX) .

Click here to see the complete history of Joseph W. Ramelli’s form 4 insider trades.

Insider Ownership Summary of Joseph W. Ramelli

Ticker Comapny Transaction Date Type of Owner
ATRX Adhera Therapeutics Inc 2012-08-20 director

Joseph W. Ramelli Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Joseph W. Ramelli Ownership Network

Ownership Network List of Joseph W. Ramelli

No Data

Ownership Network Relation of Joseph W. Ramelli

Insider Network Chart

Joseph W. Ramelli Owned Company Details

What does Adhera Therapeutics Inc do?

Who are the key executives at Adhera Therapeutics Inc?

Joseph W. Ramelli is the director of Adhera Therapeutics Inc. Other key executives at Adhera Therapeutics Inc include director & Chief Executive Officer Andrew Albert Kucharchuk , SVP Finance & Accounting Rhonda L. Stanley , and Chief Financial Officer Robert Eric Teague .

Adhera Therapeutics Inc (ATRX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Adhera Therapeutics Inc (ATRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adhera Therapeutics Inc (ATRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Adhera Therapeutics Inc (ATRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Adhera Therapeutics Inc Insider Transactions

No Available Data

Joseph W. Ramelli Mailing Address

Above is the net worth, insider trading, and ownership report for Joseph W. Ramelli. You might contact Joseph W. Ramelli via mailing address: C/o Marina Biotech, Inc., 3830 Monte Villa Parkway, Bothell Wa 98021.

Discussions on Joseph W. Ramelli

No discussions yet.